• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Ultra-high-performance liquid chromatography for the determination of exenatide in monkey plasma by tandem quadrupole mass spectrometry

    2013-12-23 06:14:52JinFengZhngChunJieShYuSunYunYunGiJiYeSunJingBinHnXinShoChunShYouXinLiWnHuiLiu
    Journal of Pharmaceutical Analysis 2013年4期

    Jin-Feng Zhng, Chun-Jie Sh, Yu Sun, Yun-Yun Gi, Ji-Ye Sun,Jing-Bin Hn, Xin Sho, Chun-N Sh, You-Xin Li, Wn-Hui Liu,,*

    aSchool of Pharmacy, Yantai University, Yantai 264003, PR China

    bState Key Laboratory of Long-acting and Targeting Drug Delivery System, Shandong Luye Pharmaceutical Co. Ltd.,Yantai 264003, PR China

    cRushan People's Hospital, Weihai 264200, PR China

    1. Introduction

    There has been an increasing incidence of type 2 diabetes in the world population recently. The use of traditional therapies for type 2 diabetes to achieve adequate glycaemic control was often limited by undesired hypoglycemic and weight gain. Moreover, it has been witnessed that sustained development of antidiabetic therapies exploits the enteroinsular axis. Exenatide (synthetic exendin-4), a human glucagon-like peptide-1 (GLP-1) analogue with a molecular weight of 4186.6 Da, is the first member of the class of GLP-1 receptor agonists [1-4]. It mimics the action of the human hormone GLP-1 that plays a major role in the maintenance of glucose homoeostasis [5], which could improve the glycaemic control through enhancing the glucose-dependent insulin secretion, suppressing the inappropriately elevated postprandial glucagon secretion, slowing the gastric emptying, and reducing the food intake with the result of bodyweight reducing [6,7].

    Exenatide has a longer half-life (about 2.4 h) than GLP-1(less than 2 min) with no rebound effect until the termination of administration. The clinical use of exenatide still requires daily (two times a day) repeated subcutaneous injections.Recently, a slow release form of exenatide has been investigated that only requires weekly intramuscular injections,which exhibits good acceptability and compliance in clinical use [8].

    To date, various methods have been developed for the quantitation of exenatide,such as immunoassay(ELISA)[8,9]and high-performance liquid chromatographic-tandem mass spectrometry (HPLC/MS/MS) method [10,11]. However, analytical ranges used in ELISA are typically limited to one to two orders of magnitude. And sometimes ELISA has poor repeatability and specificity [12]. The immunoassay methodologies also have potential interferences from endogenous compounds and require expensive antibodies and special reagents that are often difficult to obtain, which significantly lengthens the method development time and increases the cost of the experiment [11]. Compared with immunoassay methodologies, the method of UPLC/MS/MS for peptide quantitative research is potential and worthy of further exploration.The previous HPLC/MS/MS method for exenatide has a linear calibration range of 20-2000 ng/mL requiring 150 μL of blood plasma [10], although its lower limit of quantitation(LLOQ) was limited to quantitate the effective concentration of pharmacology.

    Therefore, in the present study,we investigated a rapid and sensitive UPLC/MS/MS method for the determination of exenatide levels in monkey plasma and applied this method to the evaluation of Byetta after the subcutaneous injection of 5 μg for each animal. For the first time, the UPLC/MS/MS method is performed for the determination of the plasma concentration of exenatide with lower LLOQ (0.10 ng/mL),which has great future potential to be used for the monkey and human pharmacokinetics study.

    2. Experimental

    2.1. Reagents and chemicals

    Exenatide (purity>97%) was supplied by BACHEM, Inc(Torrance, USA). Bivalirudin (purity>87%) for using as the internal standard (IS) was purchased from Shanghai TASH Biotechnology Co., Ltd. Methanol and acetonitrile are HPLC grade, purchased from Merck KGaA. Formic acid (~98%)was purchased from Fluka (Buchs, Switzerland). Ammonium hydroxide (25.0-28.0%) was purchased from LaiYang ShuangXing Chemical Co., Ltd (Shandong, China). Oasis?MCX (30 mg, 1 cc) was purchased from Waters Corporation(Milford, MA, USA). Deionized (DI) water was generated from Milli-Q water purifying system purchased from Millipore Corporation (MA, USA).

    2.2. Instrumentation and chromatographic conditions

    The UPLC/MS/MS system consisted of an Agilent 1290 series HPLC system (Agilent Technologies, Palo Alto, CA, USA)coupled to an Applied Biosystems Sciex Qtrap 5500 mass spectrometer (Applied Biosystems Sciex, Ontario, Canada)using electrospray ionization (ESI). Chromatography was performed on a ZORBAX RRHD Eclipse Plus C18 (1.8 μm,50 mm×2.1 mm)maintained at 40°C using a gradient elution with 0.2%formic acid as solvent A and methanol as solvent B.The gradient involved: 10% B for 1.5 min; a linear increase from 10% to 90% B in 1.0 min, 90% B for 0.5 min; a linear decrease from 90% to 10% B in 0.1 min; and equilibration at 10% B for 2.0 min. The flow rate was 0.5 mL/min without a split.

    Multiple reaction monitoring (MRM) at unit resolution involved transitions of the protonated forms of exenatide at m/z 1047.4→396.3 and of bivalirudin at m/z 1090.7→650.3 in the positive ion mode. Full-scan product ion mass spectra of exenatide and bivalirudin are shown in Fig.1. Optimized MS conditions were described as follows: curtain gas, gas 1 and gas 2(all nitrogen)with 35,55 and 55 units,respectively;dwell time with 100 ms; ion spray voltage with 5500 V; source temperature with 575°C; declustering potentials with 240 V for exenatide and 100 V for bivalirudin;collision energies with 42 eV (m/z 1047.4→396.3) for exenatide and 48 eV for bivalirudin (m/z 1090.7→650.3).

    2.3. Preparation of calibration standards and quality control(QC) samples

    Fig.1 The product ion scans of[M+4H]4+for exenatide(A)and[M+2H]2+ for bivalirudin (B).

    A stock solution of exenatide (1.0 mg/mL) in methanol(containing 0.1% formic acid) was diluted with methanol/Milli-Q water/0.1% formic acid (90:10:0.1, v/v/v) to give a series of standard solutions. A series of calibration standards were then prepared by spiking blank monkey plasma samples(50 μL) with 50 μL aliquots of standard solutions to give exenatide concentrations in plasma of 0.10,0.30,0.50,1.0,3.0,10 and 30 ng/mL, respectively. Quality control (QC) samples at three concentrations (0.20, 2.0 and 24 ng/mL) were prepared independently by the same procedure.Stock solution of the internal standard (IS, bivalirudin; 1.0 mg/mL) was also prepared in methanol (containing 0.1% formic acid).A working IS solution (bivalirudin, 8.5 ng/mL) was obtained by dilution of the bivalirudin stock solution with methanol/Milli-Q water/0.1% formic acid (90:10:0.1, v/v/v).

    2.4. Sample preparation

    All frozen monkey plasma samples were thawed at room temperature and subjected to SPE as follows. An aliquot of 50 μL plasma, 50 μL methanol/Milli-Q water/0.1% formic acid(90:10:0.1,v/v/v)and 50 μL IS solution were added in the 1.5 mL Eppendorf tube. The mixture was vortex-mixed for 1 min and then centrifugated at 15000×g for 5 min. After precondition of 1 mL of methanol and 0.5 mL of formic acid (0.5%) in Milli-Q water, the supernatant was transferred to the Oasis?MCX. The columns were washed with 0.5%formic acid in Milli-Q water,and then methanol/2% aqueous formic acid 96:4 (v/v). The analyte and IS were eluted with two 200 μL portions of acetonitrile/methanol/Milli-Q water/25% aqueous ammonium hydroxide(4:1:1:1.0, v/v/v/v) to 10 mL plastic tube. The collection was added with 200 μL acetonitrile/methanol/Milli-Q water/formic acid (6:5:1:0.1, v/v/v/v), and then evaporated to dryness at 50°C under a gentle stream of nitrogen.The sample was reconstituted in 50 μL methanol/water/0.1% formic acid (90:10:0.1, v/v/v) and vortexed for 30 s. A 10 μL aliquot of the sample solution was injected into the UPLC/MS/MS system.

    2.5. Method validation

    Assay validation was performed according to the FDA guidelines [13]. Specificity was performed by analyzing blank plasma samples from six different subjects.Three independent standard curves and six replicates of low, medium and high QC samples were analyzed on three different days. Linearity was analyzed by weighted linear regression (1/x2) of analyteinternal standard peak area ratios. The precision (represented by the relative standard deviation, RSD) and the accuracy(represented by the relative error, RE) were evaluated based on assay of the LLOQ, QC samples in three consecutive days,six replicates for each day. Recovery was determined by comparing peak areas of QC samples with those of postextraction spiked blank plasma. Matrix effects were evaluated by comparing peak areas of the analyte in QC post-extraction spiked blank plasma samples with those in standard solutions.

    Stability tests were conducted to evaluate the analyte stability in stock solutions and in plasma samples under different conditions. Stock solution stability was determined by the area response of analyte (at -40°C) and internal standard(at 4°C)in the stability samples with that comparing of samples prepared from fresh stock solution. Room temperature stability(2 h),processed samples stability(reinjection stability at room temperature for 12 h), freeze-thaw stability(three cycles), long-term stability at -40°C (1 month) were performed at QC samples using three replicates at each level.Samples were considered to be stable if assay values were within the acceptable limits of accuracy (±15% SD) and precision (≤15% RSD).

    2.6. Application of the method to a pharmacokinetic study in monkey

    Animal studies were all performed under the instruction of protocols required by the Animal Care and Use Committee of the Chinese Academy of Medical Sciences.

    The experiment was led by West China Hai-Qi Medical Technology Co., Ltd. Three male healthy monkeys (3.5-4.0 kg)were given subcutaneous injection of the same dose of Byetta(5 μg for each monkey). Blood samples (0.5 mL at each time point) were collected from the hind limbs vein prior to dosing and at 5 min, 15 min, 30 min, 1 h, 2 h, 4 h, 6 h, 8 h, 12 h and 24 h after dosing. Blood samples were centrifuged and plasma was separated and stored at -40°C until analysis. The plasma concentration-time profiles for exenatide in each subject were analyzed by noncompartmental analysis using DAS 2.1.

    3. Results and discussion

    3.1. Mass spectrometry

    The [M+4H]4+of exenatide was selected as the precursor ion(m/z 1047.4) because it was the principal charged species observed in the Q1 scan process. The corresponding[M+2H]2+of bivalirudin (m/z 1090.7) was chosen for the same reason. Accordingly, the transition m/z 1047.4→396.3 was selected as quantifier. The transition m/z 1090.7→650.3 was used to bivalirudin.

    3.2. Method development

    Various mobile phase combinations of acetonitrile, methanol,ammonium acetate and formic acid were investigated to optimize the chromatography for sensitivity, speed and peak shape.Methanol gave a better response than acetonitrile and the peak shape was improved by the addition of formic acid. The ZORBAX RRHD Eclipse Plus C18(1.8 μm, 50 mm×2.1 mm)was chosen because it gave the best resolution and peak shapes with minimal matrix effects.At the same time,we found that the dilution of exenatide had a great effect on the signal intensity and that the acidity of the dilution gave great contribution to the stability of exenatide. The dilution was finally confirmed as the methanol/Milli-Q water/0.1% formic acid (90:10:0.1, v/v/v).

    Isolation of exenatide from plasma is a tedious task,because of the low concentration levels and interferences induced by matrix. The result of protein precipitation was not comforting [14], which should be related to the relatively big size of the peptide drug that leads to the co-precipitation of exenatide. The recovery of reverse phase liquid-liquid extraction was low, which might be due to the related properties of amphoteric compound.According to the information,various solid-phase extractions (Waters Oasis?HLB, Waters Oasis?MCX, Waters Oasis?WAX) were investigated. Sample prepared by HLB and WAX showed the poor recovery.Oasis?MCX with appropriate condition of elution provided better recovery and less remaining endogenous interferences.The percentage of formic and aqueous ammonium in the elutions was a key factor.Glass tube and plastic tube were also investigated as the receiving vessel, and the results indicated that the glass tube had high adsorption of exenatide.It should be suggested that exenatide contained more acidic amino acids leading to the more easily glass adsorption [15,16].

    A number of potential internal standards including triptorelin, elcatonin, and diazepam were evaluated in the present study, while most of them were incompatible with the sample preparation procedure because of their physicochemical properties.Finally,bivalirudin was chosen for the suitable IS for its similar physicochemical characteristics and similar retention time. It could be presumed that bivalirudin and exenatide had more acidic amino acid than basic amino acid in their structures while some others went in the opposite direction.Moreover, the results of our study showed that the pH of compounds was an important factor in the complex elution systems of MCX column.

    Blank plasma of several animals including rat,dog,monkey and human were compared; however, there was no interference with the endogenous substances only in the blank monkey and human plasma as shown in Fig.2, which might be caused by the different kinds and contents of GLP-1 and its analogues in various species plasma.

    3.3. Method validation

    3.3.1. Selectivity and chromatography

    The assay was found to be highly specific since there were no endogenous peaks in monkey plasma at the retention times of IS and exenatide. Representative chromatograms of blank plasma and blank plasma spiked with exenatide at the LLOQ(0.10 ng/mL) were shown in Fig.3.

    3.3.2. Linearity

    Calibration curves were prepared using seven standards,and it was linear in the range of 0.10-30 ng/mL. The mean correlation coefficient (r2) was greater than 0.9986 for all curves.

    3.3.3. Precision and accuracy

    As shown in Table 1, the precision and accuracy of exenatide in the intra- and inter-day runs were within ±15% at LOQ,MOQ, and HOQ concentrations and within ±20% at LLOQ QCs.

    3.3.4. Extraction efficiency

    The recoveries of exenatide and the IS were good and reproducible. Recoveries of exenatide from the low, medium and high QC samples were 65±2%, 63±3% and 63 ±3%, respectively. The recovery of bivalirudin was 69 ± 4%.

    Fig.2 Representative MRM chromatograms of exenatide(m/z 1047.4→396.3)in four different animals blank plasma(human,monkey,dog and rat).

    Fig.3 Representative MRM chromatograms of exenatide and bivalirudin in monkey plasma. (A) Blank plasma; (B) blank plasma spiked with 0.1 ng/mL of exenatide (I) and 8.5 ng/mL bivalirudin (II); (C) plasma sample from a monkey volunteer 15 min of exenatide after the subcutaneous injection of exenatide (5 μg for each monkey).

    Table 1 Precision and accuracy for the determination of exenatide in monkey plasma (data are based on assay of six replicates on three different days).

    3.3.5. Matrix effect

    The matrix effects were shown to be minimal based on the ratios of the peak areas for exenatide in the low, medium and high post-extraction spiked blank plasma samples to the peak areas in the corresponding standard solutions; these ratios were 106±4%, 104±7% and 105±2%,respectively. Similarly the ratio of bivalirudin was 105± 8%.

    3.3.6. Stability

    The stock solutions of exenatide were stable at -40°C for at least one month and IS solutions were stable at 4°C for at least three months.

    Room temperature stability, reinjection stability, freezethaw stability and long-term stability for exenatide were investigated at the low, medium and high QC samples. The results revealed that exenatide was stable under all of the conditions examined (Table 2).

    3.4. Pharmacokinetic study

    The mean concentration-time profile of exenatide after the subcutaneous injection of exenatide is shown in Fig.4. The mean peak plasma concentration (Cmax) was 2.1±0.4 ng/mL at a time(Tmax)of 0.5 h after the injection was given.The mean area under the plasma concentration-time curve (AUC0-t) was 5.1±0.7 ng ·h/mL and the mean elimination half-life(t1/2)was 1.2±0.2h.

    4. Conclusion

    In summary, a highly sensitive and selective UPLC/MS/MS method was first developed for the determination of exenatide in monkey plasma, which had the LLOQ of 0.10 ng/mL and good accuracy and precision. The lower requirement ofmonkey plasma volume was only 50 μL, which provided the possibility for repeated analyses without increasing blood volumes. Because there was also no interference with the endogenous substances in human plasma, this method could be well applicable to the clinical pharmacokinetic research.

    Table 2 Stability of exenatide under various conditions (data are mean±SD of three replicates).

    Fig.4 Plasma concentration-time profile of subcutaneous injection of exenatide(5 μg for each monkey)to healthy monkey.Data are mean±SD for three monkeys (three males).

    This work was supported by the National Basic Research Program of China (973 Program) (No. 2010CB735602 and No. 2012CB724003). We also would like to thank Taishan Scholar Projects for their kindly supported in the method development.

    [1] P.R. Flatt, C.J. Bailey, B.D. Green, Recent advances in antidiabetic drug therapies targeting the enteroinsular axis, Curr. Drug Metab. 10 (2009) 125-137.

    [2] B.T. Srinivasan, J. Jarvis, K. Khunti, et al., Recent advances in the management of type 2 diabetes mellitus: a review, Postgrad.Med. J. 84 (2008) 525-526.

    [3] J.S. Freeman, A physiologic and pharmacological basis for implementation of incretin hormones in the treatment of type 2 diabetes mellitus, Mayo. Clin. Proc. 85 (12) (2010) 7-9.

    [4] V.R. Aroda, R. Ratner, The safety and tolerability of GLP-1 receptor agonists in the treatment of type 2 diabetes: a review,Diabetes Metab. Res. Rev 27 (2011) 528-529.

    [5] R. Jones, The safety and tolerability of GLP-1 receptor agonists in the treatment of type-2 diabetes, Int. J. Clin. Pract. 64 (2010)1403-1414.

    [6] P.A. Kothare, H. Linnebjerg, Y. Isaka, et al., Pharmacokinetics,pharmacodynamics, tolerability, and safety of exenatide in Japanese patients with type 2 diabetes mellitus, J. Clin. Pharmacol. 48 (2008) 1390.

    [7] D.P. Bradley, R. Kulstad, D.A. Schoeller, Exenatide and weight loss, Nutrition 26 (2010) 245-247.

    [8] M. Fineman, S. Flanagan, K. Taylor, et al., Pharmacokinetics and pharmacodynamics of exenatide extended-release after single and multiple dosing, Clin. Pharmacokinet. 50 (1) (2011) 69-72.

    [9] K. Kristen M, The current status of exenatide once weekly, Clin.Med. Insights: Ther. 3 (2011) 223-224.

    [10] J.R.Kehler,C.L.Bowen,S.L.Boram,et al.,Application of DBS for quantitative assessment of the peptide Exendin-4;comparison of plasma and DBS method by UPLC-MS/MS, Bioanalysis 2 (8)(2010) 1461-1464.

    [11] L. Dillen, W. Cools, L. Vereyken, et al., Comparison of triple quadrupole and high-resolution TOF-MS for quantification of peptides, Bioanalysis 4 (5) (2012) 566-575.

    [12] A.N. Hoofnaqle, M.H. Wener, The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry, J. Immunol. Methods 34 (1-2) (2009) 3-11.

    [13] Guidance for Industry Bioanalytical Method Validation,U.S.Departmentof Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research(CDER), Center for Veterinary Medicine(CVM), BP, May 2001〈http://www.fda.gov/cder/guidance/4252fnl.htm〉.

    [14] R.W.Zhang,W.T.Liu,L.L.Geng,et al.,Quantitative analysis of a novel antimicrobial peptide in rat plasma by ultra performance liquid chromatography-tandem mass spectrometry, J. Pharm.Anal. 1 (3) (2011) 192.

    [15] I.D.V. Broek, R.W. Sparidans, J.H.M. Schellens, et al., Quantitative bioanalysis of peptides by liquid chromatography coupled to(tandem)mass spectrometry,J.Chromatogr.B 872(2008)1-7.

    [16] K. Heining, T. Wirz, Determination of taspoglutide in human and animal plasma using liquid chromatography-tandem mass spectrometry with orthogonal column-switching, Anal. Chem. 81(2009) 3705-3711.

    99久久综合免费| 2018国产大陆天天弄谢| 亚洲性久久影院| 高清在线视频一区二区三区| 黄色 视频免费看| 亚洲国产精品成人久久小说| 天美传媒精品一区二区| 国产深夜福利视频在线观看| 韩国av在线不卡| av不卡在线播放| 午夜免费鲁丝| 日本黄大片高清| 久久这里有精品视频免费| 精品99又大又爽又粗少妇毛片| 另类精品久久| 人妻系列 视频| 麻豆精品久久久久久蜜桃| 下体分泌物呈黄色| 亚洲av欧美aⅴ国产| 男女免费视频国产| 母亲3免费完整高清在线观看 | 性色av一级| 午夜91福利影院| 久久精品国产自在天天线| 香蕉丝袜av| 国产在线一区二区三区精| 国产精品久久久久久精品古装| 纵有疾风起免费观看全集完整版| 亚洲精品一区蜜桃| 久久久久国产精品人妻一区二区| 中文字幕av电影在线播放| 亚洲经典国产精华液单| 久久久久国产网址| 国产白丝娇喘喷水9色精品| 久久人人爽av亚洲精品天堂| 日韩人妻精品一区2区三区| 丰满饥渴人妻一区二区三| 街头女战士在线观看网站| 香蕉精品网在线| 久久亚洲国产成人精品v| av又黄又爽大尺度在线免费看| 亚洲图色成人| 高清欧美精品videossex| 99热国产这里只有精品6| 不卡视频在线观看欧美| 女性被躁到高潮视频| 国产精品免费大片| 亚洲av欧美aⅴ国产| 国产av一区二区精品久久| 国产乱来视频区| 99热国产这里只有精品6| 人人妻人人澡人人爽人人夜夜| 新久久久久国产一级毛片| 午夜老司机福利剧场| 久久久国产一区二区| 2022亚洲国产成人精品| 在线天堂中文资源库| 韩国精品一区二区三区 | 九色成人免费人妻av| 超色免费av| www.av在线官网国产| 欧美成人午夜免费资源| av不卡在线播放| 成人国产麻豆网| 一级毛片黄色毛片免费观看视频| 熟女av电影| 久久精品国产鲁丝片午夜精品| 一本大道久久a久久精品| 亚洲欧洲日产国产| 26uuu在线亚洲综合色| 中文字幕人妻丝袜制服| 免费黄频网站在线观看国产| 亚洲综合精品二区| 国产欧美另类精品又又久久亚洲欧美| 夜夜爽夜夜爽视频| 欧美日韩av久久| 中国三级夫妇交换| 91成人精品电影| 欧美少妇被猛烈插入视频| 久久人妻熟女aⅴ| 日韩精品免费视频一区二区三区 | 免费观看无遮挡的男女| 久久这里只有精品19| 少妇高潮的动态图| 在线免费观看不下载黄p国产| 十分钟在线观看高清视频www| 亚洲成人av在线免费| 国产69精品久久久久777片| 青春草亚洲视频在线观看| 色94色欧美一区二区| 日韩精品免费视频一区二区三区 | 欧美日韩视频高清一区二区三区二| 亚洲成av片中文字幕在线观看 | 亚洲国产精品999| 女性被躁到高潮视频| 男女国产视频网站| 久久久亚洲精品成人影院| 国产伦理片在线播放av一区| 女人被躁到高潮嗷嗷叫费观| 久久精品久久精品一区二区三区| 少妇人妻久久综合中文| 免费大片黄手机在线观看| 久久狼人影院| 国产色爽女视频免费观看| 久久久久精品性色| 人人妻人人添人人爽欧美一区卜| 日韩制服骚丝袜av| 女人久久www免费人成看片| 黄色 视频免费看| 婷婷色综合www| 狂野欧美激情性xxxx在线观看| 又大又黄又爽视频免费| 男女无遮挡免费网站观看| 嫩草影院入口| 人人澡人人妻人| 成人手机av| 波多野结衣一区麻豆| 亚洲国产精品专区欧美| 大码成人一级视频| 国产精品一区二区在线不卡| 午夜福利视频精品| 国产亚洲精品久久久com| 水蜜桃什么品种好| 亚洲精品中文字幕在线视频| 狠狠精品人妻久久久久久综合| 日本91视频免费播放| 热99久久久久精品小说推荐| 大陆偷拍与自拍| 九草在线视频观看| 久久人妻熟女aⅴ| 久久免费观看电影| 亚洲精品,欧美精品| 成人黄色视频免费在线看| 日本猛色少妇xxxxx猛交久久| 黑人欧美特级aaaaaa片| 卡戴珊不雅视频在线播放| 中文乱码字字幕精品一区二区三区| 青春草国产在线视频| 女的被弄到高潮叫床怎么办| 高清在线视频一区二区三区| 国产午夜精品一二区理论片| 精品酒店卫生间| 九九在线视频观看精品| 国产av精品麻豆| 日本与韩国留学比较| 日韩精品有码人妻一区| √禁漫天堂资源中文www| 久久97久久精品| 亚洲四区av| 国产爽快片一区二区三区| 成年动漫av网址| 岛国毛片在线播放| 在线看a的网站| 中文字幕人妻熟女乱码| 又粗又硬又长又爽又黄的视频| 精品少妇久久久久久888优播| 国内精品宾馆在线| 99热这里只有是精品在线观看| 精品亚洲成a人片在线观看| 成年女人在线观看亚洲视频| 成年人免费黄色播放视频| 亚洲人成77777在线视频| 最新的欧美精品一区二区| 国产极品粉嫩免费观看在线| 啦啦啦在线观看免费高清www| 国产高清国产精品国产三级| 好男人视频免费观看在线| 中文乱码字字幕精品一区二区三区| 日韩制服丝袜自拍偷拍| 国产av一区二区精品久久| 99视频精品全部免费 在线| 男女免费视频国产| 国产国语露脸激情在线看| 欧美少妇被猛烈插入视频| 国产精品久久久久久av不卡| www日本在线高清视频| 亚洲精品中文字幕在线视频| 国产高清三级在线| 亚洲精品美女久久久久99蜜臀 | 国产av一区二区精品久久| 国产有黄有色有爽视频| 日本午夜av视频| 午夜久久久在线观看| 男男h啪啪无遮挡| 青春草国产在线视频| 亚洲欧美色中文字幕在线| 国产欧美亚洲国产| 亚洲精品视频女| 亚洲精品色激情综合| 精品少妇久久久久久888优播| 人妻少妇偷人精品九色| 成年av动漫网址| 宅男免费午夜| 亚洲一码二码三码区别大吗| 久久精品国产自在天天线| 国产成人精品婷婷| 亚洲色图综合在线观看| 免费黄色在线免费观看| 国产亚洲av片在线观看秒播厂| 国产探花极品一区二区| 制服丝袜香蕉在线| 亚洲美女视频黄频| 久久影院123| 亚洲欧美中文字幕日韩二区| 久久精品国产a三级三级三级| 欧美+日韩+精品| 日韩人妻精品一区2区三区| 国产精品国产三级国产av玫瑰| 国产成人av激情在线播放| 九色亚洲精品在线播放| 极品少妇高潮喷水抽搐| 亚洲精品一二三| 永久网站在线| 少妇人妻 视频| 色视频在线一区二区三区| 国产精品一区www在线观看| 国产日韩欧美亚洲二区| 国产成人精品福利久久| 成人手机av| 成人18禁高潮啪啪吃奶动态图| 中文字幕av电影在线播放| 五月玫瑰六月丁香| 9191精品国产免费久久| 飞空精品影院首页| 亚洲精品一二三| 亚洲av欧美aⅴ国产| 十分钟在线观看高清视频www| 久久青草综合色| 最近2019中文字幕mv第一页| 丝袜喷水一区| 波野结衣二区三区在线| 最黄视频免费看| 一边亲一边摸免费视频| 久久青草综合色| 欧美精品亚洲一区二区| 亚洲欧美色中文字幕在线| 国产精品一区二区在线观看99| 亚洲色图 男人天堂 中文字幕 | 春色校园在线视频观看| 韩国精品一区二区三区 | 极品人妻少妇av视频| 伦理电影免费视频| 成年人午夜在线观看视频| 少妇精品久久久久久久| 色网站视频免费| 最黄视频免费看| 91在线精品国自产拍蜜月| 国产精品久久久久久久久免| 久久久久久久久久成人| 成人手机av| 在线观看国产h片| 亚洲国产精品成人久久小说| 亚洲伊人色综图| 性高湖久久久久久久久免费观看| 这个男人来自地球电影免费观看 | 两个人免费观看高清视频| 制服丝袜香蕉在线| 亚洲欧美成人综合另类久久久| 国产综合精华液| 久久精品久久久久久久性| 少妇被粗大的猛进出69影院 | 日韩av免费高清视频| 亚洲高清免费不卡视频| 亚洲国产成人一精品久久久| 少妇的逼水好多| 男的添女的下面高潮视频| 自拍欧美九色日韩亚洲蝌蚪91| 一二三四中文在线观看免费高清| 啦啦啦啦在线视频资源| 熟女av电影| 这个男人来自地球电影免费观看 | h视频一区二区三区| 国产成人精品在线电影| av福利片在线| 欧美 日韩 精品 国产| 国产免费又黄又爽又色| 人人澡人人妻人| 亚洲成国产人片在线观看| 久久ye,这里只有精品| 青青草视频在线视频观看| 亚洲精品国产av蜜桃| 国产探花极品一区二区| 亚洲性久久影院| 最新的欧美精品一区二区| 久久影院123| 午夜精品国产一区二区电影| 少妇高潮的动态图| 亚洲国产av影院在线观看| 在线观看美女被高潮喷水网站| 热re99久久精品国产66热6| 久久这里有精品视频免费| 午夜av观看不卡| 日韩欧美精品免费久久| 两个人免费观看高清视频| 久久久亚洲精品成人影院| 国产精品女同一区二区软件| 99久久人妻综合| 成人毛片a级毛片在线播放| 国产精品久久久久久精品电影小说| 亚洲国产欧美在线一区| 热re99久久国产66热| 国产精品一二三区在线看| 国产伦理片在线播放av一区| 最新中文字幕久久久久| 我要看黄色一级片免费的| videos熟女内射| 免费女性裸体啪啪无遮挡网站| 国产欧美另类精品又又久久亚洲欧美| 国产精品熟女久久久久浪| 国产成人一区二区在线| 久久精品国产自在天天线| 亚洲色图综合在线观看| 99久久人妻综合| 中文字幕另类日韩欧美亚洲嫩草| 欧美人与性动交α欧美精品济南到 | 草草在线视频免费看| 亚洲欧美日韩卡通动漫| 久久久久久人人人人人| 人人妻人人澡人人爽人人夜夜| 亚洲精品aⅴ在线观看| 日本猛色少妇xxxxx猛交久久| 一本大道久久a久久精品| 赤兔流量卡办理| 欧美精品一区二区大全| 一本色道久久久久久精品综合| 一本久久精品| 亚洲av综合色区一区| 久久毛片免费看一区二区三区| 国产精品国产三级专区第一集| 色哟哟·www| 久久精品夜色国产| 亚洲精品美女久久久久99蜜臀 | 一本一本久久a久久精品综合妖精 国产伦在线观看视频一区 | 男女边吃奶边做爰视频| 亚洲第一av免费看| 亚洲精品色激情综合| 香蕉精品网在线| 只有这里有精品99| 麻豆精品久久久久久蜜桃| 伊人亚洲综合成人网| 人妻人人澡人人爽人人| 色网站视频免费| 日日摸夜夜添夜夜爱| 亚洲,欧美,日韩| 久久ye,这里只有精品| 精品人妻在线不人妻| 日韩中文字幕视频在线看片| 国产精品麻豆人妻色哟哟久久| 亚洲国产av新网站| 久久精品国产a三级三级三级| 99香蕉大伊视频| 久久精品久久久久久久性| 日韩av在线免费看完整版不卡| 在线 av 中文字幕| 亚洲一码二码三码区别大吗| 在线 av 中文字幕| 国产永久视频网站| 一二三四在线观看免费中文在 | 丰满少妇做爰视频| 国产av精品麻豆| 卡戴珊不雅视频在线播放| 黄色一级大片看看| 一二三四中文在线观看免费高清| av有码第一页| 毛片一级片免费看久久久久| 90打野战视频偷拍视频| 美国免费a级毛片| 欧美最新免费一区二区三区| 最近手机中文字幕大全| 欧美日韩一区二区视频在线观看视频在线| 国产在视频线精品| 国产有黄有色有爽视频| 久久国内精品自在自线图片| 亚洲欧美一区二区三区黑人 | 在线观看一区二区三区激情| 五月玫瑰六月丁香| 男人添女人高潮全过程视频| 午夜久久久在线观看| 精品一区二区三卡| av一本久久久久| 考比视频在线观看| av天堂久久9| 久久av网站| 在线观看国产h片| 国产又色又爽无遮挡免| 亚洲国产精品一区三区| 成年人免费黄色播放视频| 黄色怎么调成土黄色| 久久av网站| 色视频在线一区二区三区| 午夜福利,免费看| 久久热在线av| 不卡视频在线观看欧美| 啦啦啦视频在线资源免费观看| 亚洲久久久国产精品| 美女xxoo啪啪120秒动态图| 久久亚洲国产成人精品v| 国产片内射在线| 亚洲国产精品999| 人人妻人人添人人爽欧美一区卜| 在线天堂中文资源库| 久久精品久久精品一区二区三区| 黄色一级大片看看| 人妻人人澡人人爽人人| 纵有疾风起免费观看全集完整版| 国产黄色视频一区二区在线观看| 国产极品天堂在线| 国产老妇伦熟女老妇高清| 大香蕉久久网| 亚洲精品aⅴ在线观看| 99久久中文字幕三级久久日本| 国产精品一二三区在线看| 久久鲁丝午夜福利片| 亚洲av福利一区| 欧美精品亚洲一区二区| 赤兔流量卡办理| 99热国产这里只有精品6| 亚洲国产精品成人久久小说| 久久亚洲国产成人精品v| 亚洲国产av新网站| 亚洲精品第二区| 成年人免费黄色播放视频| 国产国拍精品亚洲av在线观看| 国产精品国产三级国产专区5o| 欧美日韩综合久久久久久| 亚洲情色 制服丝袜| 又黄又爽又刺激的免费视频.| 亚洲美女视频黄频| 欧美丝袜亚洲另类| 亚洲精品aⅴ在线观看| 一二三四在线观看免费中文在 | 亚洲 欧美一区二区三区| 亚洲经典国产精华液单| 老司机影院成人| av网站免费在线观看视频| 少妇人妻精品综合一区二区| 99香蕉大伊视频| 亚洲少妇的诱惑av| 啦啦啦在线观看免费高清www| 在线观看免费视频网站a站| 制服人妻中文乱码| 岛国毛片在线播放| 性色avwww在线观看| 国产免费福利视频在线观看| 一边摸一边做爽爽视频免费| 在线观看免费视频网站a站| 男人添女人高潮全过程视频| 七月丁香在线播放| 内地一区二区视频在线| 日本-黄色视频高清免费观看| 久久午夜福利片| 亚洲成人av在线免费| 亚洲婷婷狠狠爱综合网| 亚洲,欧美,日韩| 两个人看的免费小视频| 极品少妇高潮喷水抽搐| 国产极品粉嫩免费观看在线| 丰满饥渴人妻一区二区三| 久久久久久久久久久久大奶| 免费日韩欧美在线观看| 伦理电影大哥的女人| 欧美精品av麻豆av| 亚洲精品久久成人aⅴ小说| 久久久久视频综合| 黑人巨大精品欧美一区二区蜜桃 | 欧美国产精品va在线观看不卡| 久久精品人人爽人人爽视色| 色视频在线一区二区三区| 亚洲,欧美,日韩| 观看美女的网站| 欧美日本中文国产一区发布| 久久精品久久精品一区二区三区| 99国产精品免费福利视频| 久久午夜综合久久蜜桃| kizo精华| 亚洲内射少妇av| 夜夜爽夜夜爽视频| 各种免费的搞黄视频| 亚洲欧美色中文字幕在线| 精品久久蜜臀av无| 国产免费又黄又爽又色| 五月玫瑰六月丁香| 日韩视频在线欧美| 最近最新中文字幕免费大全7| 99久久人妻综合| 色吧在线观看| 免费黄频网站在线观看国产| 日韩制服骚丝袜av| 中文字幕亚洲精品专区| 欧美精品一区二区免费开放| 999精品在线视频| 黄片无遮挡物在线观看| 麻豆乱淫一区二区| 2022亚洲国产成人精品| 人妻少妇偷人精品九色| 午夜福利网站1000一区二区三区| 久久国内精品自在自线图片| 国产成人精品久久久久久| 99久国产av精品国产电影| 日本-黄色视频高清免费观看| 欧美国产精品va在线观看不卡| 久久人妻熟女aⅴ| 色婷婷久久久亚洲欧美| 日本黄大片高清| 亚洲国产精品成人久久小说| 永久免费av网站大全| 水蜜桃什么品种好| 亚洲av中文av极速乱| 免费黄色在线免费观看| 成人毛片60女人毛片免费| av电影中文网址| 亚洲av电影在线进入| 久久韩国三级中文字幕| 国产白丝娇喘喷水9色精品| 国产av国产精品国产| 十八禁网站网址无遮挡| 一区二区三区四区激情视频| 亚洲国产日韩一区二区| 亚洲色图综合在线观看| 欧美激情极品国产一区二区三区 | 久久亚洲国产成人精品v| 免费大片18禁| 亚洲,欧美精品.| 人人澡人人妻人| 日韩,欧美,国产一区二区三区| 久久青草综合色| 亚洲精品美女久久av网站| 91精品伊人久久大香线蕉| 欧美日韩综合久久久久久| 最后的刺客免费高清国语| 日韩熟女老妇一区二区性免费视频| 午夜91福利影院| 90打野战视频偷拍视频| 午夜老司机福利剧场| 天堂中文最新版在线下载| 国产精品99久久99久久久不卡 | 精品视频人人做人人爽| 国产精品人妻久久久影院| 天天影视国产精品| 最近最新中文字幕免费大全7| 日韩视频在线欧美| 2018国产大陆天天弄谢| 秋霞伦理黄片| 伦理电影免费视频| tube8黄色片| xxx大片免费视频| 两个人免费观看高清视频| 综合色丁香网| 国产精品.久久久| 夜夜骑夜夜射夜夜干| av.在线天堂| 欧美精品亚洲一区二区| 国产黄频视频在线观看| 国产成人欧美| 草草在线视频免费看| tube8黄色片| 男女边吃奶边做爰视频| 午夜福利,免费看| 国产免费视频播放在线视频| 最近中文字幕2019免费版| 婷婷色综合www| 亚洲一码二码三码区别大吗| 少妇 在线观看| 国产黄色免费在线视频| 亚洲精品456在线播放app| 国产极品粉嫩免费观看在线| 国产亚洲精品第一综合不卡 | 两个人免费观看高清视频| 久久人人爽av亚洲精品天堂| 久久鲁丝午夜福利片| 亚洲国产最新在线播放| 人成视频在线观看免费观看| 麻豆乱淫一区二区| 99热国产这里只有精品6| av黄色大香蕉| 色吧在线观看| 美女中出高潮动态图| 黑人猛操日本美女一级片| 赤兔流量卡办理| 啦啦啦中文免费视频观看日本| 亚洲成人av在线免费| 亚洲四区av| 婷婷色麻豆天堂久久| 黄色 视频免费看| 人人妻人人澡人人看| 国产精品久久久av美女十八| 激情五月婷婷亚洲| 国产成人一区二区在线| 大片免费播放器 马上看| 亚洲国产精品一区二区三区在线| 97人妻天天添夜夜摸| 午夜日本视频在线| 国产无遮挡羞羞视频在线观看| 美女主播在线视频| 精品亚洲成a人片在线观看| 午夜久久久在线观看| 欧美+日韩+精品| 丝袜美足系列| 在线天堂最新版资源| av卡一久久| 99视频精品全部免费 在线| 国产成人aa在线观看| 国产 一区精品| 极品少妇高潮喷水抽搐| 国产亚洲午夜精品一区二区久久| 色5月婷婷丁香| 国产1区2区3区精品| 满18在线观看网站| 99热这里只有是精品在线观看| 亚洲欧美成人综合另类久久久| 久久久a久久爽久久v久久| 久久久久视频综合| 97超碰精品成人国产| 欧美日韩视频高清一区二区三区二| 国产探花极品一区二区|